News

2022

May 24

Tuesday, May 24, 2022

Dechra Academy Launches New Courses on Canine Otitis Externa

Dechra is excited to launch two new course offerings on Dechra Academy, their on-demand educational platform, focusing on the diagnosis and treatment of canine otitis externa.

keyboard_arrow_right

Read more

2022

Apr 28

Thursday, April 28, 2022

Dechra acquires the rights to Zenalpha® (medetomidine and vatinoxan hydrochlorides injection)

Vetcare and Dechra announce the FDA approval of Zenalpha®

keyboard_arrow_right

Read more

2022

Apr 27

Wednesday, April 27, 2022

Dechra Announces VOHC Acceptance for Water Additive

Dechra Veterinary Products is pleased to announce that its VETRADENT® Liquid Water Additive has received the seal of acceptance to Help Control Tartar from the Veterinary Oral Health Council (VOHC). The seal has been granted for dogs after properly demonstrating both safety and efficacy.

keyboard_arrow_right

Read more

2022

Mar 04

Friday, March 4, 2022

Dechra acquires the rights to Malaseb®

Dechra is pleased to announce the licensing rights of the Malaseb® brand of dermatology products in the United States with Dermcare of Australia.

keyboard_arrow_right

Read more

2022

Jan 13

Thursday, January 13, 2022

Dechra acquires the rights to Laverdia™-CA1 (verdinexor tablets)

Dechra Veterinary Products is pleased to announce that Dechra has acquired the rights to Laverdia™-CA1 (verdinexor tablets) from Anivive Lifesciences, Inc.

keyboard_arrow_right

Read more

2022

Jan 07

Friday, January 7, 2022

Dechra acquires Isoflurane and Sevoflurane from Halocarbon Life Sciences

Dechra is pleased to announce the acquisition of the veterinary approved Isoflurane®, USP Inhalant Anesthetic and Sevoflurane®, USP Inhalant Anesthetic from Halocarbon.

keyboard_arrow_right

Read more

2022

Jan 04

Tuesday, January 4, 2022

Dechra announces partnership with Bioiberica to boost companion animal offering in the United States

Dechra is pleased to announce a joint collaboration with Bioiberica, a global Life Science company committed to improving the health and well-being of people, animals and plants, for the license and distribution of its Atopivet® range of dermatology products for cats and dogs in the United States.

keyboard_arrow_right

Read more

2021

Dec 03

Friday, December 3, 2021

DSM Biomedical and Dechra partner to fuel innovation in animal injury recovery

DSM Biomedical announces a joint collaboration with Dechra Limited for the license and distribution of devices that create isolated solutions of highly concentrated cells and / or platelets for use with horses and companion animals.

keyboard_arrow_right

Read more

2021

Oct 29

Friday, October 29, 2021

Dechra acquires Sucromate™ Equine (deslorelin acetate) sterile suspension from Thorn Bioscience L.L.C

This acquisition expands Dechra’s equine portfolio in the reproductive category.

keyboard_arrow_right

Read more

2021

Oct 21

Thursday, October 21, 2021

Dechra receives approval for Amoxicillin and Clavulanate Potassium Oral Suspension Drops

Approval expands Dechra’s growing companion animal products (CAP) range of anti-infectives.

keyboard_arrow_right

Read more

keyboard_arrow_up